Statin use in the US for secondary prevention of cardiovascular disease remains suboptimal

Q Ngo-Metzger, S Zuvekas, P Shafer… - The Journal of the …, 2019 - Am Board Family Med
Background: Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of
mortality in the United States. The purpose of this study is to examine the rates of statin use …

Prevalence of statin use for primary prevention of atherosclerotic cardiovascular disease by race, ethnicity, and 10-year disease risk in the US: National Health and …

JA Jacobs, DK Addo, AR Zheutlin… - JAMA …, 2023 - jamanetwork.com
Importance The burden of atherosclerotic cardiovascular disease (ASCVD) in the US is
higher among Black and Hispanic vs White adults. Inclusion of race in guidance for statin …

Assessment of trends in statin therapy for secondary prevention of atherosclerotic cardiovascular disease in US adults from 2007 to 2016

X Yao, ND Shah, BJ Gersh, F Lopez-Jimenez… - JAMA Network …, 2020 - jamanetwork.com
Importance Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in the US,
with studies indicating substantial rates of nonadherence to and undertreatment with statin …

Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition …

MD Chobufo, SR Regner, I Zeb… - European journal of …, 2022 - academic.oup.com
Aims To assess the current state of statin use, factors associated with non-use, and estimate
the burden of potentially preventable atherosclerotic cardiovascular diseases (ASCVD) …

High-intensity statin use among patients with atherosclerosis in the US

AJ Nelson, K Haynes, S Shambhu, Z Eapen… - Journal of the American …, 2022 - jacc.org
Background Preventive therapy among patients with established atherosclerotic
cardiovascular disease (ASCVD) is generally underused. Whether new guideline …

[HTML][HTML] Estimated impact of US preventive services task force recommendations on use and cost of statins for cardiovascular disease prevention

Q Ngo-Metzger, SH Zuvekas, AS Bierman - Journal of General Internal …, 2018 - Springer
Abstract Background US Preventive Services Task Force (USPSTF) released new
recommendations on statin use for atherosclerotic cardiovascular disease (ASCVD) …

Statin use in primary prevention of atherosclerotic cardiovascular disease according to 5 major guidelines for sensitivity, specificity, and number needed to treat

MB Mortensen, BG Nordestgaard - JAMA cardiology, 2019 - jamanetwork.com
Importance Five major guidelines on statin use for primary prevention of atherosclerotic
cardiovascular disease (ASCVD) have been published since 2014: the National Institute for …

[HTML][HTML] Statin use for the primary prevention of cardiovascular disease in adults: A systematic review for the US Preventive Services Task Force

R Chou, A Cantor, T Dana, J Wagner, A Ahmed, R Fu… - 2022 - europepmc.org
Background Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in
the United States. A 2016 review for the US Preventive Services Task Force (USPSTF) found …

Primary prevention with statins: ACC/AHA risk-based approach versus trial-based approaches to guide statin therapy

MB Mortensen, S Afzal, BG Nordestgaard… - Journal of the American …, 2015 - jacc.org
Background: Guidelines recommend initiating primary prevention for atherosclerotic
cardiovascular disease (ASCVD) with statins based on absolute ASCVD risk assessment …

Cardiovascular risk and statin use in the United States

ME Johansen, LA Green, A Sen… - The Annals of Family …, 2014 - Annals Family Med
PURPOSE Statins reduce the risk of mortality and coronary artery disease in individuals at
high cardiovascular risk. Using nationally representative data, we examined the …